Your browser doesn't support javascript.
loading
Pre-travel advice, attitudes and hepatitis A and B vaccination rates among travellers from seven countries†.
Heywood, Anita E; Nothdurft, Hans; Tessier, Dominique; Moodley, Melissa; Rombo, Lars; Marano, Cinzia; De Moerlooze, Laurence.
Afiliação
  • Heywood AE; School of Public Health and Community Medicine, Faculty of Medicine, UNSW Australia, Level 3, Samuels Building, Sydney 2052, Australia a.heywood@unsw.edu.au.
  • Nothdurft H; University of Munich, Munich, Germany.
  • Tessier D; Family Medicine, Groupe Sante Voyage, Quebec, Canada Unité Hospitalière de Recherche, d'enseignement et de soins sur le sida, CHUM, University of Montreal, Montreal, Canada.
  • Moodley M; Healthcare, Ipsos MORI, London, UK.
  • Rombo L; Centre for Clinical Research, Sormland County Council and Uppsala University, Eskilstuna, Sweden.
  • Marano C; Medical Affairs, GSK Vaccines, Wavre, Belgium.
  • De Moerlooze L; Medical Affairs, GSK Vaccines, Wavre, Belgium.
J Travel Med ; 24(1)2016 Jul.
Article em En | MEDLINE | ID: mdl-27738112
BACKGROUND: Knowledge about the travel-associated risks of hepatitis A and B, and the extent of pre-travel health-advice being sought may vary between countries. METHODS: An online survey was undertaken to assess the awareness, advice-seeking behaviour, rates of vaccination against hepatitis A and B and adherence rates in Australia, Finland, Germany, Norway, Sweden, the UK and Canada between August and October 2014. Individuals aged 18-65 years were screened for eligibility based on: travel to hepatitis A and B endemic countries within the past 3 years, awareness of hepatitis A, and/or combined hepatitis A&B vaccines; awareness of their self-reported vaccination status and if vaccinated, vaccination within the last 3 years. Awareness and receipt of the vaccines, sources of advice, reasons for non-vaccination, adherence to recommended doses and the value of immunization reminders were analysed. RESULTS: Of 27 386 screened travellers, 19 817 (72%) were aware of monovalent hepatitis A or combined A&B vaccines. Of these 13 857 (70%) had sought advice from a healthcare provider (HCP) regarding combined hepatitis A&B or monovalent hepatitis A vaccination, and 9328 (67%) were vaccinated. Of 5225 individuals eligible for the main survey (recently vaccinated = 3576; unvaccinated = 1649), 27% (841/3111) and 37% (174/465) of vaccinated travellers had adhered to the 3-dose combined hepatitis A&B or 2-dose monovalent hepatitis A vaccination schedules, respectively. Of travellers partially vaccinated against combined hepatitis A&B or hepatitis A, 84% and 61%, respectively, believed that they had received the recommended number of doses. CONCLUSIONS: HCPs remain the main source of pre-travel health advice. The majority of travellers who received monovalent hepatitis A or combined hepatitis A&B vaccines did not complete the recommended course. These findings highlight the need for further training of HCPs and the provision of reminder services to improve traveller awareness and adherence to vaccination schedules.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Viagem / Conhecimentos, Atitudes e Prática em Saúde / Vacinação / Vacinas contra Hepatite B / Vacinas contra Hepatite A / Hepatite A / Hepatite B Tipo de estudo: Etiology_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Viagem / Conhecimentos, Atitudes e Prática em Saúde / Vacinação / Vacinas contra Hepatite B / Vacinas contra Hepatite A / Hepatite A / Hepatite B Tipo de estudo: Etiology_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article